CHICAGO -- For extended anticoagulation after venous thromboembolism (VTE) in patients with active cancer, a lower dose of apixaban (Eliquis) was just as effective as a higher dose -- and safer, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback